维普中文期刊产品整合服务
248篇 您的检索式:作者名="Figlin"
    题名 作者 年代 出处 被引量
1Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial显示文摘Robert J Motzer Bernard Escudier Stéphane Oudard Thomas E Hutson Camillo Porta Sergio Bracarda Viktor Grünwald John A Thompson Robert A Figlin Norbert Hollaender Gladys Urbanowitz William J Berg Andrea Kay David Lebwohl Alain Ravaud 2008The Lancet2008,,9637:2
2SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE显示文摘JEAN-JACQUES PATARD OLEG SHVARTS JOHN S. LAM ALLAN J. PANTUCK HYUNG L. KIM VINCENZO FICARRA LUCA CINDOLO KEN-RYU HAN ALEXANDRE DE LA TAILLE JACQUES TOSTAIN WALTER ARTIBANI CLAUDE C. ABBOU BERNARD LOBEL DOMINIQUE K. CHOPIN ROBERT A. FIGLIN PETER F.A. MULDE 2004The Journal of Urology2004,,6:2
3Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin显示文摘Reckamp KL Gardner BK Figlin RA 2008J Thorac Oncol2008,3,2:1
4Bevacizttmab with or without erlotinib in metastatic renal cell carcinoma(RCC)显示文摘Bukowskl RM Kabbinavar F Figlin RA 2006J Clin Oncol2006,24,18:1
5Supportive care versus supportive care and chemotherapy in metastatic nonsmall cell lung cancer: Doses chemotherapy make a difference?显示文摘 Figlin RA Haskell CM 1998Cancer1998,6,1:1
6Phosphatidylinositol - 3 - kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol - 3 - kinase/Akt inhibitors 显示文摘Porta C Figlin RA 2009J Urol2009,182,6:1
7A novel personalized vaccine approach in combina- tion with targeted therapy in advanced renal cell carcinoma显示文摘FIGLIN RA 2014Immunotherapy2014,6,3:1
8Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody显示文摘Kenneth A Foon Xiao-Dong Yang Louis M Weiner Arie S Belldegrun Robert A Figlin Jeffrey Crawford Eric K Rowinsky Janice P Dutcher Nicholas J Vogelzang Jared Gollub John A Thompson Garry Schwartz Ronald M Bukowski Lorin K Roskos Gisela M Schwab 2004International Journal of Radiation Oncology Biology Physics2004,,3:1
9Surveillance following radical or partial nephrectomy for renal cell carcinoma显示文摘LAM JS LEPPERT JT FIGLIN RA 2005Curr Urol Rep2005,6,:1
10The Usefulness of F-18 Deoxyglucose Whole-body Positron Emission Tomography (PET) for Re-staging of Renal Cell Cancer显示文摘SAFAEI A FIGLIN R HOH CK 2002Clin Nephrol2002,57,1:1
11Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and man- agement of recurrent disease显示文摘Janzen NK Kim HL Figlin RA 2003Urol Clin North Am2003,30,4:1
12Kidney cancer:progress and controversies in neoadjuvant therapy显示文摘Posadas E M Figlin R A 2014Nat Rev Urol2014,11,5:1
13Role of molecular markers in the diagnosis and therapy of renal cell carcinoma显示文摘John S. Lam John T. Leppert Robert A. Figlin Arie S. Belldegrun 2005Urology2005,,5:1
14The role of molecular markers in the staging of renal cell carcinoma显示文摘Leppert JT Pantuck A J Figlin RA 2007BJU Int2007,99,5:1
15Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease 显示文摘Janzen NK Kin HL Figlin RA 2003Urol Clin North Am2003,30,:1
16A phase Ⅱ study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer显示文摘 Figlin R Hochster H 1998Cancer J Sci Am1998,4,1:1
17Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease显示文摘JANZEN NK KIM HL FIGLIN RA 2003Urol Clin North Am2003,30,:1
18Safety and efficacy results of the advanced renal cell carcinoma sorafenih expanded access program in North America 显示文摘Stadler WM Figlin RA McDermott DF 2010Cancer2010,116,5:1
19Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-or显示文摘PATIL S FIGLIN R A HUTSON T E 2012Br J Cancer2012,106,15:1
20Renal cell carcinoma: recent progress and future directions显示文摘MuMers P'Figlin R 1997Cancer Res1997,57,22:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费